Vnitr Lek 2024, 70(1):E33-E39 | DOI: 10.36290/vnl.2024.015

Bleeding disorders - overview for clinical practice

Monika Bradáčová, Antonín Hluší
Hemato-onkologická klinika FNOL a LF UP v Olomouci

bleeding disorders are situations manifested clinically by bleeding or an increased risk of bleeding caused by various reasons. In addition to anatomical causes, the main reasons for haemorrhage include impaired haemostasis. From the clinical point of view these are clinical situations in which bleeding is inadequate to inducing stimulus or begins spontaneously and may manifested itself as difficult-to-stop bleeding or prolonged bleeding after operation or after injury. The basis is disturbance of balance due to a quantitative or qualitative disturbance of one of the hemostatic mechanisms, the causes can be combined. The aim of this article is to provide an overview of these conditions in defined scope, highlighting aspects useful in routine clinical practice.

Keywords: bleeding, disseminated intravascular coagulopathy, haemophilia, haemostasis, immune thrombocytopenia, thrombocytopathy, thrombotic thrombocytopenic purpura, von Willebrand disease.

Accepted: February 23, 2024; Published: February 26, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bradáčová M, Hluší A. Bleeding disorders - overview for clinical practice. Vnitr Lek. 2024;70(1):E33-39. doi: 10.36290/vnl.2024.015.
Download citation

References

  1. Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515. Go to original source... Go to PubMed...
  2. Salaj P. Congenital and acquired bleeding disorders. Vnitr Lek. 2018;64(5):547-58. Go to original source...
  3. Hrachovinová I. Diagnostic strategies in disorders of hemostasis. Vnitr Lek. 2018;64(5):537-44. Go to original source...
  4. Provan D, Arnold DM, Bussel JB, Chong BH, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Advances. 2019;3(22):3780-817. Go to original source... Go to PubMed...
  5. Kozak T, Cermak J, Cerna O, et al. Doporučení České hematologické společnosti pro diagnostiku a léčbu imunitní trombocytopenie dospělých. Transfuze Hematol. Dnes. 2023; 29(1):68-77.
  6. Sukumar S, Lämmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med. 2021;10(3):536. Go to original source... Go to PubMed...
  7. Nicolas D, Nicolas S, Hodgens A, et al. Heparin-Induced Thrombocytopenia. StatPearls Publishing LLC; 2023 [cit 2023-07-10]. Dostupné z WWW:
  8. Jinna S, Khandhar PB. Thrombocytopenia. StatPearls Publishing LLC; 2023 [cit 2023-10-30]. Dostupné z WWW:
  9. Toro C, Nicoli ER, Malicdan MC, et al. Chediak-Higashi Syndrome. University of Washington, Seattle; 1993. [cit 2023-10-30]. Dostupné z WWW:
  10. Bain BJ, Bhavnani M. Gray platelet syndrome. Am J Hematol. 2011;86(12):1027-1027. Go to original source... Go to PubMed...
  11. Mehta P, Reddivari AKR. Hemophilia. Int StatPearls Publishing; 2023 [cit 2023-04-28]. Dostupné z WWW:
  12. Sabih A, Babiker HM. Von Willebrand Disease. Int StatPearls Publishing; 2023 [cit 2023-04-28]. Dostupné z WWW:
  13. Weyand AC, Flood VH. Von Willebrand Disease: Current Status of Diagnosis and Management. Hematol Oncol Clin North Am. 2021;35(6):1085-101. Go to original source... Go to PubMed...
  14. Menegatti M, Biguzzi E, Peyvandi F. Management of rare acquired bleeding disorders. Hematology. 2019;2019(1):80-7. Go to original source... Go to PubMed...
  15. Papageorgiou C, Jourdi G, Adjambri E, et al. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies. Clin Appl Thromb Hemost. 2018;24(9_suppl):8S-28S. Go to original source... Go to PubMed...
  16. Macri A, Wilson AM, Shafaat O, et al. Osler-Weber-Rendu Disease. StatPearls Publishing LLC; 2023 [cit 2023-04-24]. Dostupné z WWW:
  17. Hetland LE, Susrud KS, Lindahl KH, et al. Henoch-Schönlein Purpura: A Literature Review. Acta Derm Venereol. 2017;97(10):1160-6. Go to original source... Go to PubMed...
  18. Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Reviews. 2015;29(1):17-24. Go to original source... Go to PubMed...
  19. May JE, Wolberg AS, Lim MY. Disorders of Fibrinogen and Fibrinolysis. Hematol Oncol Clin North Am. 2021;35(6):1197-217. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.